3 ms·
Does the FDA have the authority to deny marketing approval for minor improvements? Mylan pushed generics off the market by making a better cap or something, th
by maxerickson 10y ago
Does the FDA have the authority to deny marketing approval for minor improvements?
Mylan pushed generics off the market by making a better cap or something, the FDA should just say no, that improvement is nice but it isn't enough to give you exclusive marketing rights. If you want to incorporate it into your product, license it to your competitors for cheap.
- wyldfire 10y agoFDA's genesis was bound pretty close to marketing. If you wanted to sell "Aunt Eliza's Magic Elixir" and claim that it "cures all ails: backaches, headaches, etc", you are required to show evidence that validates those claims. See Pure Food and Drug Act. FDA's responsibility is mutually exclusive with USPTO which would approve/deny patents based on "novelty".
- maxerickson 10y agoI'm not suggesting that the FDA could deny a patent. I'm suggesting that the FDA could simply refuse to approve the new version of a product. In the case where there are generics and the improvement is small, it doesn't matter if the company decides to take their ball and go home. It might be a fine line to walk, but the improvements to the Epipen don't seem to be very substantial (it's kind of hard to figure out what the improvements are with so much coverage of the recent events).
- wyldfire 10y agoWhat would be the basis on which they would deny a new product? If you were Mylan, you would bring suit. Courts would not side with the FDA, because they'd be wrong. The FDA's responsibility is dictated by legislation and there's nothing in the US Code that describes "you can't release new products if the new design isn't sufficiently improved." Legislators have all the power. If they can agree, they can say "Woo party free EpiPens for everyone, put it in the budget." FDA has some small amount of judgment they can apply within reason to restrict products that fail to comply with the law.
- maxerickson 10y agoThey could perhaps deny the application on the basis that the claimed benefits of the safety feature don't exist. https://www.law.cornell.edu/uscode/text/21/355 https://www.law.cornell.edu/uscode/text/21/355 (5) evaluated on the basis of the information submitted to him as part of the application and any other information before him with respect to such drug, there is a lack of substantial evidence that the drug will have the effect it purports or is represented to have under the conditions of use prescribed, recommended, or suggested in the proposed labeling thereof; or (6) the application failed to contain the patent information prescribed by subsection Maybe it's a stretch, but a marginally safer but much less accessible product actually doesn't improve the situation for the public. I'm partly suggesting here that if the FDA doesn't have the authority, maybe they should.
- FireBeyond 10y agoAs someone who has worked with EpiPens for seven years now, administering them to patients weekly, if not more, it's very hard for me to find any claim of "improving the product" to be more than lip service. Certainly I don't consider the drug beyond active ingredient, but in the delivery mechanism (where they've also claimed "significant improvements and refinements", very little has changed. The shape of the container is a bit different, the 'window' to see the drug (to look for cloudiness or discoloration) is a little bigger (mind you, such a window is more akin to "empty space in product coloring and branding"). Certainly, I know some things might happen "behind the scenes". Maybe they found a more durable spring for the needle (not that was ever a problem), or such. But yes, I struggle to see it as anything more than patent extension. Which is why, after our relatively small county, which THROWS OUT $100,000 of EpiPens a year in the Medic One system (which we are mandated to carry by state law) is moving to train EMTs to draw up epi from $2.80 vials, themselves.
- bradleyjg 10y ago>> Does the FDA have the authority to deny marketing approval for minor improvements? They certainly don't. Look at Nexium, it is something close to a blatant scam but the FDA approved it and between Medicare and Medicaid alone the federal government has rewarded the scammers (AstraZeneca) with billions of dollars never mind private insurance companies.
- maxerickson 10y agoNexium doesn't appear to be relevant to the question I am asking, as Omeprazole was not pulled from the market when it was released (it's maybe a similarly stupid situation). The additional issue with auto-injectors is that knowing how to correctly use a particular one is important, so there is a legitimate reason to make sure that generics work the same way as the branded version. This means that if the branded version adds a patented safety feature, then there won't be generics for a while.
- Alex3917 10y agoIt's not just Nexium, the majority of the best selling drugs in the U.S. are no more effective than placebos or generics.
- JustSomeNobody 10y agoHonest question, how is Nexium a scam?
- ceejayoz 10y agohttps://en.wikipedia.org/wiki/AstraZeneca#Nexium https://en.wikipedia.org/wiki/AstraZeneca#Nexium Nexium is just pre-broken-down Prilosec, which had just run out of patent protection. They then manipulated the results to make it look more effective so they could market it as such: > AstraZeneca's scientists had misrepresented their research on the drug's efficiency, saying "Instead of using presumably comparable doses [of each drug], the company's scientists used Nexium in higher dosages. They compared 20 and 40 mg Nexium with 20 mg Prilosec. With the cards having been marked in that way, Nexium looked like an improvement – which however was only small and shown in only two of the three studies."
- shanacarp 10y agoFollow-up question based on your question: Medical Devices ALSO need approval from the FDA. Why is the Epi-Pen body not approved separately from the Drug, allowing the body to be sold without epinephrine and to be filled with whatever, including generic epinephrine from a vial?